Equity · Healthcare
GLPG
NGMGalapagos Nv (GLPG)
Lakefront Biotherapeutics NV price graph
This price chart is drawn by TradingView, from their own data, in an embed loaded from their servers.
Which funds hold Galapagos Nv (GLPG)?
7 of the 45 institutional funds we track reported a Galapagos Nv position for the quarter ended 30 Sep 2026 — a combined 46.2M USD; the latest of those filings landed 16 Nov 2026.
| Fund | Position | Shares | Value | Shares q/q |
|---|---|---|---|---|
| Renaissance Technologies | Held (±25%) | 424,700 | 12.6M USD | +4.1% |
| D. E. Shaw & Co. | Added | 325,660 | 9.7M USD | +64.6% |
| Citadel Advisors | Added | 312,634 | 9.3M USD | +253.9% |
| Point72 Asset Management | Held (±25%) | 232,756 | 6.9M USD | −13.7% |
| Two Sigma Investments | Added | 167,218 | 5.0M USD | +104.6% |
| Marshall Wace | Added | 78,456 | 2.3M USD | +142.2% |
| Millennium Management | Trimmed | 17,566 | 521K USD | −90.3% |
What do people ask about Galapagos Nv (GLPG)?
Which funds own Galapagos Nv?7 of 45
7 of the 45 funds we track reported a Galapagos Nv position for the quarter ended 30 Sep 2026, per their SEC Form 13F filings. The largest reported positions were Renaissance Technologies, D. E. Shaw & Co. and Citadel Advisors. See Funds

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.
References
- TradingViewthe price chart widget, drawn by TradingView from their own data
- SEC EDGAR13F filings
- Company websiteAbout text: the company's own website, summarised in our own words